There is good evidence from clinical studies demonstrating that the change of HDAC2 expression and HDAC activity may contribute to the increase of inflammatory gene expression and corticosteroid insensitivity in COPD [26, 27]. Here, HDAC9 is linked to chronic obstructive pulmonary disease.